| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | chloride:bicarbonate antiporter activity | 4.58e-06 | 13 | 183 | 4 | GO:0140900 | |
| GeneOntologyMolecularFunction | bicarbonate:monoatomic anion antiporter activity | 4.58e-06 | 13 | 183 | 4 | GO:0140829 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | MRE11 MYO1C DNAH10 KIF1B DHX38 ABCC11 TWNK CHD1L RFC1 DDX54 MLH1 NAV2 MACF1 DNA2 HSPA9 SLC27A5 TDRD12 | 5.25e-05 | 614 | 183 | 17 | GO:0140657 |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | DNAH10 KIF1B DHX38 ABCC11 TWNK CHD1L RFC1 DDX54 MLH1 NAV2 MACF1 DNA2 HSPA9 TDRD12 | 5.86e-05 | 441 | 183 | 14 | GO:0016887 |
| GeneOntologyMolecularFunction | helicase activity | 1.07e-04 | 158 | 183 | 8 | GO:0004386 | |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on DNA | 1.72e-04 | 127 | 183 | 7 | GO:0008094 | |
| GeneOntologyMolecularFunction | bicarbonate transmembrane transporter activity | 2.01e-04 | 32 | 183 | 4 | GO:0015106 | |
| GeneOntologyMolecularFunction | solute:inorganic anion antiporter activity | 2.01e-04 | 32 | 183 | 4 | GO:0005452 | |
| GeneOntologyMolecularFunction | RNA-dependent RNA polymerase activity | 2.49e-04 | 3 | 183 | 2 | GO:0003968 | |
| GeneOntologyMolecularFunction | sodium,bicarbonate:chloride antiporter activity | 2.49e-04 | 3 | 183 | 2 | GO:0140892 | |
| GeneOntologyMolecularFunction | DNA helicase activity | 2.60e-04 | 62 | 183 | 5 | GO:0003678 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | DNAH10 ENPP3 KIF1B DHX38 ATL3 ABCC11 TWNK CHD1L RFC1 ARL10 DDX54 MLH1 NAV2 MACF1 DNA2 GFM1 HSPA9 TBCC TDRD12 | 2.65e-04 | 839 | 183 | 19 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | DNAH10 ENPP3 KIF1B DHX38 ATL3 ABCC11 TWNK CHD1L RFC1 ARL10 DDX54 MLH1 NAV2 MACF1 DNA2 GFM1 HSPA9 TBCC TDRD12 | 2.69e-04 | 840 | 183 | 19 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | DNAH10 ENPP3 KIF1B DHX38 ATL3 ABCC11 TWNK CHD1L RFC1 ARL10 DDX54 MLH1 NAV2 MACF1 DNA2 GFM1 HSPA9 TBCC TDRD12 | 2.69e-04 | 840 | 183 | 19 | GO:0016818 |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | DNAH10 KIF1B DHX38 ATL3 ABCC11 TWNK CHD1L RFC1 ARL10 DDX54 MLH1 NAV2 MACF1 DNA2 GFM1 HSPA9 TBCC TDRD12 | 2.85e-04 | 775 | 183 | 18 | GO:0017111 |
| GeneOntologyMolecularFunction | cadherin binding | MRE11 DNAJB1 DOCK9 CDH23 EVPL UNC45A PRDX6 EEF1G CDH22 SH3GLB1 MACF1 | 3.05e-04 | 339 | 183 | 11 | GO:0045296 |
| GeneOntologyMolecularFunction | monoatomic anion transmembrane transporter activity | 4.93e-04 | 151 | 183 | 7 | GO:0008509 | |
| GeneOntologyMolecularFunction | high-affinity L-glutamate transmembrane transporter activity | 8.20e-04 | 5 | 183 | 2 | GO:0005314 | |
| GeneOntologyMolecularFunction | glutamate:sodium symporter activity | 8.20e-04 | 5 | 183 | 2 | GO:0015501 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on a nucleic acid | MRE11 POLR2A POLR2B DHX38 GATC TWNK CHD1L RFC1 DDX54 MLH1 NAV2 RARS2 DNA2 NIPBL TDRD12 | 9.12e-04 | 645 | 183 | 15 | GO:0140640 |
| GeneOntologyMolecularFunction | promoter-specific chromatin binding | 9.97e-04 | 83 | 183 | 5 | GO:1990841 | |
| GeneOntologyMolecularFunction | inorganic anion transmembrane transporter activity | 1.03e-03 | 171 | 183 | 7 | GO:0015103 | |
| GeneOntologyMolecularFunction | chloride transmembrane transporter activity | 1.04e-03 | 125 | 183 | 6 | GO:0015108 | |
| GeneOntologyMolecularFunction | CoA carboxylase activity | 1.22e-03 | 6 | 183 | 2 | GO:0016421 | |
| GeneOntologyMolecularFunction | sodium:bicarbonate symporter activity | 1.22e-03 | 6 | 183 | 2 | GO:0008510 | |
| GeneOntologyMolecularFunction | MAP kinase kinase kinase kinase activity | 1.22e-03 | 6 | 183 | 2 | GO:0008349 | |
| GeneOntologyMolecularFunction | organic anion transmembrane transporter activity | SLC4A8 SLC26A4 ABCC11 SLC1A3 SLC1A6 SLC4A10 SLC26A11 MFSD10 SLC27A5 | 1.57e-03 | 293 | 183 | 9 | GO:0008514 |
| GeneOntologyMolecularFunction | histone reader activity | 1.69e-03 | 26 | 183 | 3 | GO:0140566 | |
| GeneOntologyMolecularFunction | ligase activity, forming carbon-carbon bonds | 1.70e-03 | 7 | 183 | 2 | GO:0016885 | |
| Domain | - | 1.84e-05 | 6 | 184 | 3 | 3.90.1290.10 | |
| Domain | Plectin | 3.20e-05 | 7 | 184 | 3 | PF00681 | |
| Domain | Plectin_repeat | 3.20e-05 | 7 | 184 | 3 | IPR001101 | |
| Domain | PLEC | 3.20e-05 | 7 | 184 | 3 | SM00250 | |
| Domain | Tudor | 2.04e-04 | 30 | 184 | 4 | IPR002999 | |
| Domain | PIH1 | 2.88e-04 | 3 | 184 | 2 | PF08190 | |
| Domain | PIH1 | 2.88e-04 | 3 | 184 | 2 | IPR012981 | |
| Domain | Tubulin-bd_cofactor_C_dom | 2.88e-04 | 3 | 184 | 2 | IPR012945 | |
| Domain | VPS13 | 2.88e-04 | 3 | 184 | 2 | IPR026847 | |
| Domain | K_chnl_volt-dep_ERG | 2.88e-04 | 3 | 184 | 2 | IPR003967 | |
| Domain | VPS13_mid_rpt | 2.88e-04 | 3 | 184 | 2 | PF16910 | |
| Domain | VPS13 | 2.88e-04 | 3 | 184 | 2 | PF16908 | |
| Domain | VPS13_N2 | 2.88e-04 | 3 | 184 | 2 | IPR031646 | |
| Domain | VPS13_mid_rpt | 2.88e-04 | 3 | 184 | 2 | IPR031642 | |
| Domain | TBCC | 2.88e-04 | 3 | 184 | 2 | PF07986 | |
| Domain | CNH | 3.16e-04 | 14 | 184 | 3 | SM00036 | |
| Domain | CNH | 3.92e-04 | 15 | 184 | 3 | PF00780 | |
| Domain | CNH | 3.92e-04 | 15 | 184 | 3 | PS50219 | |
| Domain | CNH_dom | 3.92e-04 | 15 | 184 | 3 | IPR001180 | |
| Domain | DUF2476 | 5.72e-04 | 4 | 184 | 2 | PF10630 | |
| Domain | SHR-BD | 5.72e-04 | 4 | 184 | 2 | IPR009543 | |
| Domain | Carboxyl_trans | 5.72e-04 | 4 | 184 | 2 | PF01039 | |
| Domain | COA_CT_CTER | 5.72e-04 | 4 | 184 | 2 | PS50989 | |
| Domain | PRR23 | 5.72e-04 | 4 | 184 | 2 | IPR018903 | |
| Domain | COA_CT_NTER | 5.72e-04 | 4 | 184 | 2 | PS50980 | |
| Domain | MAPKKKK | 5.72e-04 | 4 | 184 | 2 | IPR021160 | |
| Domain | VPS13_C | 5.72e-04 | 4 | 184 | 2 | PF16909 | |
| Domain | COA_CT_N | 5.72e-04 | 4 | 184 | 2 | IPR011762 | |
| Domain | COA_CT_C | 5.72e-04 | 4 | 184 | 2 | IPR011763 | |
| Domain | VPS13_C | 5.72e-04 | 4 | 184 | 2 | IPR031645 | |
| Domain | SHR-BD | 5.72e-04 | 4 | 184 | 2 | PF06650 | |
| Domain | Carboxyl_trans | 5.72e-04 | 4 | 184 | 2 | IPR000022 | |
| Domain | Cadherin_CS | 7.37e-04 | 109 | 184 | 6 | IPR020894 | |
| Domain | CADHERIN_1 | 8.91e-04 | 113 | 184 | 6 | PS00232 | |
| Domain | Cadherin | 8.91e-04 | 113 | 184 | 6 | PF00028 | |
| Domain | CADHERIN_2 | 9.32e-04 | 114 | 184 | 6 | PS50268 | |
| Domain | - | 9.32e-04 | 114 | 184 | 6 | 2.60.40.60 | |
| Domain | 1-cysPrx_C | 9.47e-04 | 5 | 184 | 2 | PF10417 | |
| Domain | CAP/MinC_C | 9.47e-04 | 5 | 184 | 2 | IPR016098 | |
| Domain | CARP_motif | 9.47e-04 | 5 | 184 | 2 | IPR006599 | |
| Domain | - | 9.47e-04 | 5 | 184 | 2 | 2.160.20.70 | |
| Domain | Na/HCO3_transpt | 9.47e-04 | 5 | 184 | 2 | IPR003024 | |
| Domain | C-CAP_CF_C-like | 9.47e-04 | 5 | 184 | 2 | IPR017901 | |
| Domain | CARP | 9.47e-04 | 5 | 184 | 2 | SM00673 | |
| Domain | Peroxiredoxin_C | 9.47e-04 | 5 | 184 | 2 | IPR019479 | |
| Domain | C_CAP_COFACTOR_C | 9.47e-04 | 5 | 184 | 2 | PS51329 | |
| Domain | CA | 9.76e-04 | 115 | 184 | 6 | SM00112 | |
| Domain | Cadherin-like | 1.02e-03 | 116 | 184 | 6 | IPR015919 | |
| Domain | Cadherin | 1.12e-03 | 118 | 184 | 6 | IPR002126 | |
| Domain | TUDOR | 1.44e-03 | 23 | 184 | 3 | PS50304 | |
| Domain | S04_transporter_CS | 1.96e-03 | 7 | 184 | 2 | IPR018045 | |
| Domain | NA_DICARBOXYL_SYMP_1 | 1.96e-03 | 7 | 184 | 2 | PS00713 | |
| Domain | NA_DICARBOXYL_SYMP_2 | 1.96e-03 | 7 | 184 | 2 | PS00714 | |
| Domain | SDF | 1.96e-03 | 7 | 184 | 2 | PF00375 | |
| Domain | - | 1.96e-03 | 7 | 184 | 2 | 1.10.3860.10 | |
| Domain | ANION_EXCHANGER_2 | 1.96e-03 | 7 | 184 | 2 | PS00220 | |
| Domain | Na-dicarboxylate_symporter | 1.96e-03 | 7 | 184 | 2 | IPR001991 | |
| Domain | ANION_EXCHANGER_1 | 1.96e-03 | 7 | 184 | 2 | PS00219 | |
| Domain | AhpC/TSA | 1.96e-03 | 7 | 184 | 2 | IPR000866 | |
| Domain | AhpC-TSA | 1.96e-03 | 7 | 184 | 2 | PF00578 | |
| Domain | Na-dicarboxylate_symporter_CS | 1.96e-03 | 7 | 184 | 2 | IPR018107 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | UTP6 MRE11 CCDC22 MYO1C TRIP6 USP11 POLR2A POLR2B DHX38 ATL3 CHD1L MCCC2 UNC45A PFKL RFC1 BIRC6 PHB1 EEF1G RPL7L1 UPF2 MAP4K5 MDC1 EIF2B3 DDX54 AHCY MLH1 RACGAP1 MACF1 SAMM50 HERC2 NIPBL NUP160 HSPA9 | 2.85e-13 | 1353 | 186 | 33 | 29467282 |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | RBM11 MYO1C VEZT USP11 ACOT9 VPS13C POLR2B OBSL1 GATC TWNK ITPRID2 BIRC6 PHB1 VPS13D RPL7L1 WIZ RPAP1 STX18 UPF2 RAB3GAP2 EIF2B3 PANK4 DDX54 MTMR3 RARS2 SAMM50 ATXN10 HERC2 PIH1D1 GFM1 NEURL4 NUP160 HSPA9 | 4.32e-12 | 1496 | 186 | 33 | 32877691 |
| Pubmed | DNAJB1 VEZT USP11 SF3A1 PRDX4 POLR2B ASCC1 OBSL1 GATC TWNK MCCC2 ITPRID2 UNC45A CDC42BPB PHB1 TUBGCP6 RPL7L1 RPAP1 STX18 MAP4K5 RAB3GAP2 PANK4 DDX54 MACF1 SEMA6A SAMM50 ATXN10 HERC2 DNA2 PIH1D1 NEURL4 HSPA9 | 1.81e-11 | 1487 | 186 | 32 | 33957083 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | UTP6 MRE11 DNAJB1 MYO1C DNAH10 VPS13C SF3A1 PRDX4 POLR2A POLR2B DHX38 DUOX2 MCCC2 UNC45A PFKL RFC1 PRDX6 PHB1 EEF1G RPL7L1 RAB3GAP2 MDC1 DDX54 AHCY RACGAP1 SAMM50 ATXN10 GFM1 NIPBL NUP160 HSPA9 | 2.99e-11 | 1425 | 186 | 31 | 30948266 |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | UTP6 MRE11 EPPK1 SF3A1 POLR2A POLR2B OBSL1 ITPRID2 PFKL PRDX6 PHB1 EEF1G RPL7L1 RPAP1 MDC1 DDX54 AHCY RACGAP1 MACF1 ATXN10 HERC2 NEURL4 NIPBL NUP160 HSPA9 | 2.87e-10 | 1024 | 186 | 25 | 24711643 |
| Pubmed | Interactome Analysis of Human Phospholipase D and Phosphatidic Acid-Associated Protein Network. | DNAJB1 ACOT9 PRDX4 UNC45A SLC1A3 PHB1 ARL10 EIF2B3 SLITRK5 FUCA2 PIH1D1 GFM1 NUP160 MFSD10 | 4.57e-10 | 282 | 186 | 14 | 35007762 |
| Pubmed | MYO1C USP11 POLR2B ASCC1 OBSL1 ATL3 CHD1L MCCC2 UNC45A SLC1A3 TUBGCP6 VPS13D RPAP1 PANK4 DDX54 RARS2 SAMM50 HERC2 DNA2 | 8.16e-10 | 606 | 186 | 19 | 36538041 | |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | MRE11 DNAJB1 EPPK1 TRIP6 ACOT9 SF3A1 PRDX4 POLR2A POLR2B DHX38 MCCC2 UNC45A PFKL RFC1 BIRC6 SLC1A3 PRDX6 PHB1 EEF1G MDC1 PRSS21 DDX54 AHCY MACF1 TRAPPC3 PIH1D1 NIPBL HSPA9 | 2.48e-09 | 1415 | 186 | 28 | 28515276 |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | UTP6 MRE11 EPPK1 MYO1C ACOT9 SF3A1 POLR2B DHX38 ASCC1 EVPL ITPRID2 UNC45A PFKL RFC1 PHB1 EEF1G RPL7L1 UPF2 MDC1 DDX54 AHCY RACGAP1 SAMM50 PATJ NUP160 HSPA9 | 3.97e-09 | 1257 | 186 | 26 | 36526897 |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | MRE11 DNAJB1 TRIP6 USP11 SF3A1 PRDX4 POLR2A POLR2B KIF1B DHX38 DPP3 UNC45A PFKL BIRC6 PPID CRMP1 EEF1G SH3GLB1 RAB3GAP2 EIF2B3 PANK4 AHCY MACF1 ATXN10 PIH1D1 TNPO3 NUP160 HSPA9 | 4.55e-09 | 1455 | 186 | 28 | 22863883 |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | UTP6 MRE11 DNAJB1 ANK1 ACACB ACOT9 SF3A1 PRDX4 POLR2B DHX38 ATL3 CHD1L MCCC2 PFKL RFC1 PRDX6 PHB1 EEF1G RPL7L1 UPF2 EIF2B3 DDX54 NIPBL TNPO3 NUP160 HSPA9 | 1.04e-08 | 1318 | 186 | 26 | 30463901 |
| Pubmed | UTP6 MRE11 EPPK1 MYO1C USP11 SF3A1 PRDX4 POLR2A DHX38 RFC1 BIRC6 MDC1 DDX54 MACF1 HERC2 NIPBL NUP160 HSPA9 | 1.69e-08 | 653 | 186 | 18 | 22586326 | |
| Pubmed | TTYH1 TNFRSF25 DCHS2 RBM11 PPRC1 USP11 KIF1B MCF2L2 OBSL1 NCAM2 CDC42BPB BFSP1 CRMP1 SETDB1 WIZ STX18 WIF1 AHCY MTMR3 MACF1 CERCAM ATXN10 HERC2 NIPBL HSPA9 | 2.70e-08 | 1285 | 186 | 25 | 35914814 | |
| Pubmed | TDRD15 ACACB MYO1C VPS13C KIF1B PCDHB2 MCCC2 BIRC6 CDC42BPB MKS1 PHB1 EEF1G ARL10 WIZ UNC5C SLITRK5 PIH1D1 NUP160 HSPA9 | 4.44e-08 | 777 | 186 | 19 | 35844135 | |
| Pubmed | MRE11 CCDC22 POLR2A POLR2B PPID PRDX6 CRMP1 DNAAF2 RAB3GAP2 FDXR MLH1 RACGAP1 MACF1 PIH1D1 KNL1 | 4.45e-08 | 472 | 186 | 15 | 38943005 | |
| Pubmed | DNAJB1 CCDC22 MYO1C TRIP6 VEZT POLR2A POLR2B DHX38 ITPRID2 BIRC6 CDC42BPB PPP3CC WIZ DDX54 MTMR3 MLH1 LRP6 ATXN10 HERC2 PIH1D1 NEURL4 KNL1 | 5.44e-08 | 1049 | 186 | 22 | 27880917 | |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | UTP6 MRE11 DNAJB1 RANBP10 TRIP6 USP11 PRDX4 OBSL1 ATL3 EVPL UNC45A TBCCD1 ARL10 RPAP1 EIF2B3 DDX54 MTMR3 ATXN10 GFM1 TNPO3 NUP160 | 7.04e-08 | 974 | 186 | 21 | 28675297 |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | DCHS2 ANK1 ACACB TRIP6 SPEG DOCK9 POLR2A POLR2B ASCC1 TOGARAM2 PHB1 VPS13D DDX54 SCN9A NAV2 | 8.70e-08 | 497 | 186 | 15 | 36774506 |
| Pubmed | EPPK1 MYO1C VPS13C BTBD17 NFASC PFKL CDC42BPB SLC1A3 CRMP1 PHB1 MACF1 HERC2 TNR GABBR1 | 9.47e-08 | 430 | 186 | 14 | 32581705 | |
| Pubmed | MRE11 ISLR2 MYO1C TRIP6 VEZT RBL1 USP11 POLR2A POLR2B ASCC1 OBSL1 TUBGCP6 SETDB1 LIMK2 WIZ PANK4 MLH1 MACF1 RARS2 DNA2 CDH16 KNL1 | 1.58e-07 | 1116 | 186 | 22 | 31753913 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | MRE11 DNAJB1 RBM11 ACACB SF3A1 POLR2A DHX38 UNC45A PFKL RFC1 PRDX6 EEF1G WIZ AHCY MLH1 MACF1 PIH1D1 NIPBL HSPA9 KNL1 | 1.64e-07 | 934 | 186 | 20 | 33916271 |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | MRE11 DNAJB1 RANBP10 RBL1 SF3A1 KIF1B OBSL1 CDH23 PPID MKS1 PHB1 DNAAF2 SETDB1 SH3GLB1 STX18 EIF2B3 KATNIP SAMM50 ATXN10 TRAPPC3 PIH1D1 NEURL4 TNPO3 NUP160 | 1.85e-07 | 1321 | 186 | 24 | 27173435 |
| Pubmed | RANBP10 EPPK1 RBL1 PRDX4 POLR2A POLR2B TWNK PANK4 SAMM50 ATXN10 HERC2 NEURL4 TNPO3 HSPA9 KNL1 | 2.13e-07 | 533 | 186 | 15 | 25544563 | |
| Pubmed | SLC4A8 ACACB VEZT ACOT9 DOCK9 MCCC2 PFKL BIRC6 CDC42BPB SLC1A3 PHB1 EEF1G RAB3GAP2 SLC4A10 SLITRK5 MACF1 TRAPPC3 GFM1 UNC13A HSPA9 GABBR1 PHACTR1 | 2.24e-07 | 1139 | 186 | 22 | 36417873 | |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | MRE11 DNAJB1 EPPK1 USP11 SF3A1 PRDX4 POLR2B UNC45A PFKL RFC1 PRDX6 EEF1G SH3GLB1 RAB3GAP2 EIF2B3 PANK4 AHCY MACF1 ATXN10 TRAPPC3 PATJ HSPA9 | 2.59e-07 | 1149 | 186 | 22 | 35446349 |
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | DNAJB1 MYO1C USP11 PRDX4 POLR2A POLR2B CHD1L MCCC2 UNC45A PFKL RFC1 BIRC6 PRDX6 PHB1 EEF1G PANK4 AHCY RARS2 ATXN10 DNA2 GFM1 NUP160 HSPA9 | 3.01e-07 | 1257 | 186 | 23 | 37317656 |
| Pubmed | MYO1C USP11 ACOT9 POLR2B MCCC2 RFC1 RAB3GAP2 EIF2B3 PANK4 RACGAP1 ATXN10 GFM1 TNPO3 NUP160 HSPA9 | 3.99e-07 | 560 | 186 | 15 | 35241646 | |
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | EPPK1 MYO1C TRIP6 USP11 SF3A1 POLR2A POLR2B KIF1B DHX38 UNC45A CDC42BPB MEN1 RPL7L1 RAB3GAP2 EIF2B3 AHCY RACGAP1 RARS2 ATXN10 HERC2 NEURL4 TNPO3 NUP160 | 4.35e-07 | 1284 | 186 | 23 | 17353931 |
| Pubmed | MRE11 DNAJB1 TRIP6 PRDX4 POLR2A POLR2B DHX38 ASCC1 TWNK ITPRID2 UNC45A PFKL CDC42BPB MEN1 EEF1G RPL7L1 PPP3CC WIZ STX18 MDC1 MLH1 MACF1 HERC2 PATJ NIPBL | 4.80e-07 | 1497 | 186 | 25 | 31527615 | |
| Pubmed | RANBP10 SLC4A8 MAN2B2 DHX38 TTC14 BIRC6 CDC42BPB PRDX6 VPS13D SH3GLB1 SLITRK5 MACF1 NEURL4 NUP160 | 4.93e-07 | 493 | 186 | 14 | 15368895 | |
| Pubmed | 5.36e-07 | 130 | 186 | 8 | 12421765 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | RANBP10 EPPK1 CTC1 PPRC1 SPEG DOCK9 POLR2A TWNK BIRC6 CDC42BPB WIZ RPAP1 KCNH2 CSAD EIF2B3 MTMR3 NAV2 GPC2 HERC2 TNPO3 ANKRD16 | 5.59e-07 | 1105 | 186 | 21 | 35748872 |
| Pubmed | Compartmentalization of the SUMO/RNF4 pathway by SLX4 drives DNA repair. | MRE11 ACACB SF3A1 PRDX4 DHX38 EEF1G WIZ MDC1 DDX54 AHCY MLH1 HSPA9 | 5.74e-07 | 357 | 186 | 12 | 37059091 |
| Pubmed | MYO1C KIF1B EVPL CHD1L CDC42BPB EEF1G MAP4K5 MLH1 MACF1 NIPBL MAP4K2 HSPA9 | 6.27e-07 | 360 | 186 | 12 | 33111431 | |
| Pubmed | MRE11 RBM11 ACACB MYO1C DNAH10 TRIP6 USP11 TWNK MCCC2 PPARG RFC1 PHB1 SETDB1 RPL7L1 WIZ TTC31 MDC1 DDX54 RACGAP1 LRP6 ATXN10 TRAPPC3 HERC2 NIPBL | 7.53e-07 | 1429 | 186 | 24 | 35140242 | |
| Pubmed | DNAJB1 RANBP10 CCDC22 MYO1C PRDX4 POLR2B ASCC1 ITPRID2 UNC45A PFKL RFC1 PHB1 EEF1G RPL7L1 STX18 MDC1 EIF2B3 PANK4 DDX54 RACGAP1 RARS2 SAMM50 TRAPPC3 TNPO3 | 8.62e-07 | 1440 | 186 | 24 | 30833792 | |
| Pubmed | VEZT USP11 ACOT9 GATC BIRC6 ARL10 SH3GLB1 STX18 FDXR AHCY SEMA6A ATXN10 TRAPPC3 FUCA2 TNPO3 HSPA9 | 1.00e-06 | 686 | 186 | 16 | 28380382 | |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | MRE11 DNAJB1 RBM11 EPPK1 MYO1C TRIP6 SF3A1 PRDX4 KIF1B ATL3 PFKL RFC1 PPID PRDX6 PHB1 SETDB1 EEF1G AHCY ATXN10 TRAPPC3 NUP160 HSPA9 KNL1 | 1.27e-06 | 1367 | 186 | 23 | 32687490 |
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | UTP6 MRE11 EPPK1 POLR2A POLR2B DHX38 BIRC6 EEF1G RPAP1 STX18 UPF2 RAB3GAP2 FDXR AHCY NIPBL NUP160 | 1.40e-06 | 704 | 186 | 16 | 29955894 |
| Pubmed | MRE11 DNAJB1 SF3A1 KIF1B UNC45A PRDX6 PHB1 EEF1G MAP4K5 RAB3GAP2 AHCY SLITRK5 LRP6 MACF1 PATJ HSPA9 | 1.51e-06 | 708 | 186 | 16 | 39231216 | |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | DNAJB1 MYO1C SF3A1 POLR2A DHX38 TTC14 MCCC2 RFC1 PRDX6 PHB1 EEF1G RPL7L1 MDC1 FDXR DDX54 RACGAP1 GFM1 HSPA9 KNL1 | 1.71e-06 | 989 | 186 | 19 | 36424410 |
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | MRE11 EPPK1 SF3A1 POLR2A PFKL PRDX6 SETDB1 EEF1G MDC1 NIPBL NUP160 | 1.97e-06 | 332 | 186 | 11 | 32786267 |
| Pubmed | PPRC1 SPEG DOCK9 KIF1B OBSL1 EPG5 SETDB1 RPAP1 RAB3GAP2 MTMR3 MACF1 KATNIP | 2.25e-06 | 407 | 186 | 12 | 12693553 | |
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | UTP6 SF3A1 POLR2A POLR2B DHX38 UNC45A MEN1 WIZ UPF2 MDC1 DDX54 | 2.55e-06 | 341 | 186 | 11 | 32971831 |
| Pubmed | Defining the Protein-Protein Interaction Network of the Human Protein Tyrosine Phosphatase Family. | DNAJB1 RANBP10 TRIP6 ACOT9 PRDX4 POLR2B CDC42BPB PRDX6 PHB1 ARL10 RPL7L1 STX18 MTMR3 SAMM50 ATXN10 PIH1D1 GFM1 TNPO3 | 2.97e-06 | 931 | 186 | 18 | 27432908 |
| Pubmed | MRE11 DNAJB1 RANBP10 USP11 SF3A1 PRDX4 POLR2A POLR2B ASCC1 MCCC2 RFC1 PRDX6 PHB1 EEF1G RPAP1 AHCY MTMR3 TRAPPC3 PIH1D1 TNPO3 NUP160 HSPA9 | 3.07e-06 | 1335 | 186 | 22 | 29229926 | |
| Pubmed | The Tumor Suppressor CIC Directly Regulates MAPK Pathway Genes via Histone Deacetylation. | EPPK1 TRIP6 USP11 SF3A1 PRDX4 POLR2A POLR2B RFC1 PRDX6 EEF1G PPP3CC WIZ NUP160 HSPA9 | 3.50e-06 | 583 | 186 | 14 | 29844126 |
| Pubmed | 5.21e-06 | 234 | 186 | 9 | 36243803 | ||
| Pubmed | 6.12e-06 | 128 | 186 | 7 | 30995482 | ||
| Pubmed | MRE11 CTC1 PPRC1 DOCK9 POLR2B DHX38 TTC14 PFKL SLC1A3 CRMP1 MEN1 TBCCD1 UNC5C MACF1 FUCA2 ACCSL PATJ DNA2 PHACTR1 | 6.38e-06 | 1084 | 186 | 19 | 11544199 | |
| Pubmed | EPPK1 MYO1C POLR2B MCCC2 UNC45A RFC1 BIRC6 PPID CDC42BPB EEF1G MDC1 PRSS21 AHCY MLH1 RACGAP1 MACF1 CERCAM NIPBL TNPO3 NUP160 HSPA9 | 6.84e-06 | 1297 | 186 | 21 | 33545068 | |
| Pubmed | Network organization of the huntingtin proteomic interactome in mammalian brain. | MAN2B2 ANK1 PHF20 KIF1B NFASC PFKL SLC1A3 PRDX6 CRMP1 PHB1 EEF1G AHCY ATXN10 HSPA9 | 7.17e-06 | 621 | 186 | 14 | 22794259 |
| Pubmed | Tyrosine dephosphorylation of H2AX modulates apoptosis and survival decisions. | 8.26e-06 | 8 | 186 | 3 | 19234442 | |
| Pubmed | MRE11 DNAJB1 CCDC22 TRIP6 POLR2A POLR2B MCCC2 UNC45A PRDX6 WIZ RAB3GAP2 MDC1 PATJ | 9.14e-06 | 549 | 186 | 13 | 38280479 | |
| Pubmed | Large-scale proteomics and phosphoproteomics of urinary exosomes. | DNAJB1 MYO1C VPS13C ENPP3 SLC26A4 ABCC11 EVPL PFKL CDC42BPB PRDX6 MELTF VPS13D WIZ AHCY SAMM50 PATJ SLC26A11 NIPBL | 9.80e-06 | 1016 | 186 | 18 | 19056867 |
| Pubmed | CCDC22 VEZT VPS13C PRDX4 POLR2A POLR2B BIRC6 PPID SETDB1 RAB3GAP2 MDC1 RACGAP1 PATJ GFM1 KNL1 | 1.06e-05 | 733 | 186 | 15 | 34672954 | |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | MRE11 ANK1 VPS13C POLR2A NFASC EVPL PFKL BIRC6 EEF1G WIZ RPAP1 PLXNA4 SLC26A11 TNR BANK1 | 1.11e-05 | 736 | 186 | 15 | 29676528 |
| Pubmed | ∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis. | DNAJB1 EPPK1 MYO1C ABCC11 UNC45A PFKL PRDX6 MEN1 PHB1 RAB3GAP2 AHCY ATXN10 TNPO3 HSPA9 | 1.14e-05 | 647 | 186 | 14 | 26618866 |
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | MRE11 DNAJB1 TRIP6 DOCK9 EVPL ITPRID2 UNC45A PRDX6 EEF1G SH3GLB1 NAV2 MACF1 PATJ | 1.24e-05 | 565 | 186 | 13 | 25468996 |
| Pubmed | NOVA-dependent regulation of cryptic NMD exons controls synaptic protein levels after seizure. | 1.26e-05 | 27 | 186 | 4 | 23359859 | |
| Pubmed | MYO1C ACOT9 SF3A1 POLR2A POLR2B KIF1B ASCC1 MCCC2 UNC45A PFKL RFC1 PPID PRDX6 EEF1G DDX54 AHCY MLH1 RACGAP1 PATJ HSPA9 | 1.32e-05 | 1247 | 186 | 20 | 27684187 | |
| Pubmed | DNAJB1 PRDX4 UNC45A BIRC6 SLC1A3 PRDX6 RPAP1 STX18 RARS2 SAMM50 ATXN10 HERC2 TNPO3 NUP160 | 1.35e-05 | 657 | 186 | 14 | 36180527 | |
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | UTP6 DNAJB1 VEZT POLR2B OBSL1 UNC45A PHB1 RPL7L1 RPAP1 STX18 RAB3GAP2 EIF2B3 LRP6 SAMM50 ATXN10 TRAPPC3 TNPO3 | 1.38e-05 | 942 | 186 | 17 | 31073040 |
| Pubmed | Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms. | MRE11 DNAJB1 RANBP10 CCDC22 MAN2B2 ACOT9 ASCC1 ATL3 SLC1A3 MTMR3 FUCA2 HERC2 DNA2 NEURL4 TNPO3 | 1.48e-05 | 754 | 186 | 15 | 33060197 |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | CCDC22 ACACB TRIP6 ACOT9 VPS13C PRDX4 POLR2B KIF1B MCCC2 UNC45A PPID MEN1 HERC2 PIH1D1 NEURL4 HSPA9 | 1.57e-05 | 853 | 186 | 16 | 28718761 |
| Pubmed | 1.65e-05 | 149 | 186 | 7 | 25184681 | ||
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | UTP6 MRE11 RBL1 USP11 SF3A1 POLR2A OBSL1 TWNK CHD1L PFKL PPARG MEN1 WIZ PANK4 AHCY NUP160 | 1.66e-05 | 857 | 186 | 16 | 25609649 |
| Pubmed | USP11 DOCK9 KIF1B LAMA4 BIRC6 CDC42BPB EEF1G SH3GLB1 UPF2 MACF1 ATXN10 HSPA9 | 1.68e-05 | 497 | 186 | 12 | 23414517 | |
| Pubmed | RUFY1 binds Arl8b and mediates endosome-to-TGN CI-M6PR retrieval for cargo sorting to lysosomes. | 1.81e-05 | 344 | 186 | 10 | 36282215 | |
| Pubmed | RANBP10 SLC4A8 NFASC CDC42BPB SLC1A3 CRMP1 WIZ RACGAP1 MACF1 TRAPPC3 HERC2 TNR NEURL4 NIPBL UNC13A HSPA9 PHACTR1 | 1.83e-05 | 963 | 186 | 17 | 28671696 | |
| Pubmed | 1.96e-05 | 153 | 186 | 7 | 10718198 | ||
| Pubmed | TRIM29 regulates the assembly of DNA repair proteins into damaged chromatin. | 2.23e-05 | 31 | 186 | 4 | 26095369 | |
| Pubmed | Functional analysis of secreted and transmembrane proteins critical to mouse development. | 2.23e-05 | 31 | 186 | 4 | 11431694 | |
| Pubmed | 2.41e-05 | 11 | 186 | 3 | 19270065 | ||
| Pubmed | SMC1 is a downstream effector in the ATM/NBS1 branch of the human S-phase checkpoint. | 2.41e-05 | 11 | 186 | 3 | 11877377 | |
| Pubmed | 2.84e-05 | 2 | 186 | 2 | 29741614 | ||
| Pubmed | 2.84e-05 | 2 | 186 | 2 | 17584298 | ||
| Pubmed | K+-Driven Cl-/HCO3- Exchange Mediated by Slc4a8 and Slc4a10. | 2.84e-05 | 2 | 186 | 2 | 38674160 | |
| Pubmed | 2.84e-05 | 2 | 186 | 2 | 19596783 | ||
| Pubmed | [Semaphorin/plexin signal regulates lamina-restricted projection of hippocampal mossy fiber]. | 2.84e-05 | 2 | 186 | 2 | 21089322 | |
| Pubmed | Differential roles of glial and neuronal glutamate transporters in Purkinje cell synapses. | 2.84e-05 | 2 | 186 | 2 | 16177048 | |
| Pubmed | 2.84e-05 | 2 | 186 | 2 | 16647773 | ||
| Pubmed | The interplay between hMLH1 and hMRE11: role in MMR and the effect of hMLH1 mutations. | 2.84e-05 | 2 | 186 | 2 | 18373977 | |
| Pubmed | The complex role of Wnt ligands in type 2 diabetes mellitus and related complications. | 2.84e-05 | 2 | 186 | 2 | 34042263 | |
| Pubmed | 2.84e-05 | 2 | 186 | 2 | 19515853 | ||
| Pubmed | Chondroitin sulfate proteoglycan tenascin-R regulates glutamate uptake by adult brain astrocytes. | 2.84e-05 | 2 | 186 | 2 | 24337573 | |
| Pubmed | 2.84e-05 | 2 | 186 | 2 | 27162448 | ||
| Pubmed | 2.84e-05 | 2 | 186 | 2 | 17397051 | ||
| Pubmed | Plexin-A4 Mediates Cytotoxic T-cell Trafficking and Exclusion in Cancer. | 2.84e-05 | 2 | 186 | 2 | 34815265 | |
| Pubmed | 2.84e-05 | 2 | 186 | 2 | 37199156 | ||
| Pubmed | 2.84e-05 | 2 | 186 | 2 | 9722619 | ||
| Pubmed | 2.84e-05 | 2 | 186 | 2 | 23395899 | ||
| Pubmed | 2.84e-05 | 2 | 186 | 2 | 38138960 | ||
| Pubmed | 2.84e-05 | 2 | 186 | 2 | 17377820 | ||
| Pubmed | 2.84e-05 | 2 | 186 | 2 | 17185389 | ||
| Pubmed | Structural requirements for association of neurofascin with ankyrin. | 2.84e-05 | 2 | 186 | 2 | 9804856 | |
| Pubmed | MAN2B2 ACOT9 ENPP3 POLR2B PFKL PHB1 EEF1G EIF2B3 PRSS21 AHCY CERCAM FUCA2 HSPA9 | 2.89e-05 | 613 | 186 | 13 | 22268729 | |
| Pubmed | HDAC11 MYO1C KIF1B NFASC NCAM2 PFKL CDC42BPB SLC1A3 PRDX6 CRMP1 EEF1G UPF2 SORCS2 PLXNA4 SLC4A10 MACF1 SAMM50 TRAPPC3 TNR UNC13A HSPA9 | 2.94e-05 | 1431 | 186 | 21 | 37142655 | |
| Pubmed | 3.08e-05 | 225 | 186 | 8 | 12168954 | ||
| Pubmed | 3.20e-05 | 12 | 186 | 3 | 10783165 | ||
| Interaction | DNAJC7 interactions | DNAJB1 CTC1 USP11 VPS13C POLR2B OBSL1 MCCC2 PFKL PPARG MKS1 PHB1 TUBGCP6 EEF1G RPAP1 PANK4 SAMM50 ATXN10 HERC2 DNA2 NEURL4 KNL1 | 3.63e-10 | 425 | 184 | 21 | int:DNAJC7 |
| Interaction | EED interactions | UTP6 MRE11 RBM11 ACACB MYO1C RBL1 VPS13C SF3A1 PRDX4 POLR2A POLR2B HS1BP3 MCCC2 UNC45A PFKL BIRC6 CDC42BPB MEN1 PHB1 EEF1G WIZ RAB3GAP2 MDC1 DDX54 MACF1 SAMM50 ATXN10 HERC2 NIPBL TNPO3 NUP160 HSPA9 MFSD10 | 8.76e-07 | 1445 | 184 | 33 | int:EED |
| Interaction | CLEC16A interactions | MYO1C USP11 POLR2B ASCC1 OBSL1 ATL3 CHD1L MCCC2 UNC45A SLC1A3 TUBGCP6 VPS13D RPAP1 PANK4 DDX54 RARS2 SAMM50 HERC2 DNA2 | 5.24e-06 | 629 | 184 | 19 | int:CLEC16A |
| Interaction | TOP3B interactions | RANBP10 RBM11 EPPK1 MYO1C CTC1 PPRC1 SPEG DOCK9 POLR2A KIF1B TWNK UNC45A PFKL BIRC6 CDC42BPB PHB1 WIZ RPAP1 UPF2 KCNH2 CSAD MDC1 EIF2B3 MTMR3 NAV2 RACGAP1 GPC2 HERC2 DNA2 TNPO3 ANKRD16 | 1.00e-05 | 1470 | 184 | 31 | int:TOP3B |
| Interaction | PLD6 interactions | 1.05e-05 | 151 | 184 | 9 | int:PLD6 | |
| Interaction | FBXO22 interactions | DCHS2 ANK1 ACACB TRIP6 SPEG DOCK9 POLR2A POLR2B ASCC1 TOGARAM2 PHB1 VPS13D DDX54 SCN9A NAV2 PIH1D1 | 3.79e-05 | 540 | 184 | 16 | int:FBXO22 |
| Interaction | EGLN3 interactions | MRE11 DNAJB1 RANBP10 MYO1C TRIP6 PRDX4 POLR2A POLR2B OBSL1 CHD1L MCCC2 UNC45A BIRC6 TUBGCP6 DNAAF2 RPAP1 STX18 EIF2B3 PANK4 MTMR3 RACGAP1 RARS2 SAMM50 ATXN10 GFM1 NUP160 KNL1 | 4.98e-05 | 1296 | 184 | 27 | int:EGLN3 |
| Interaction | MAP1LC3C interactions | 5.06e-05 | 72 | 184 | 6 | int:MAP1LC3C | |
| Interaction | SLC6A4 interactions | EPPK1 MYO1C VPS13C BTBD17 NFASC PFKL CDC42BPB SLC1A3 CRMP1 PHB1 MACF1 HERC2 TNR GABBR1 | 5.11e-05 | 437 | 184 | 14 | int:SLC6A4 |
| Interaction | SIRT7 interactions | UTP6 MRE11 EPPK1 MYO1C USP11 SF3A1 PRDX4 POLR2A DHX38 PPARG RFC1 BIRC6 MDC1 DDX54 MACF1 HERC2 NIPBL NUP160 HSPA9 | 5.34e-05 | 744 | 184 | 19 | int:SIRT7 |
| Interaction | SNW1 interactions | MRE11 HDAC11 EPPK1 RBL1 SF3A1 DHX38 TTC14 OBSL1 CHD1L UNC45A PFKL MEN1 EEF1G WIZ AHCY MLH1 RACGAP1 NIPBL MAP4K2 | 5.63e-05 | 747 | 184 | 19 | int:SNW1 |
| Interaction | GNB2 interactions | RBM11 EPPK1 SLC4A8 ACACB MYO1C ACOT9 VPS13C SPEG POLR2B PFKL PHB1 RPAP1 FDXR ATXN10 KNL1 | 6.06e-05 | 502 | 184 | 15 | int:GNB2 |
| Interaction | BIRC3 interactions | UTP6 MRE11 DNAJB1 MYO1C DNAH10 SF3A1 PRDX4 POLR2A POLR2B DHX38 DUOX2 MCCC2 PFKL RFC1 PRDX6 PHB1 EEF1G RPL7L1 MDC1 DDX54 AHCY RACGAP1 SAMM50 ATXN10 GFM1 NUP160 HSPA9 | 8.12e-05 | 1334 | 184 | 27 | int:BIRC3 |
| Interaction | USP4 interactions | MRE11 DNAJB1 CTC1 RBL1 USP11 SF3A1 FAM110D EVPL ITPRID2 UNC45A BFSP1 | 8.32e-05 | 293 | 184 | 11 | int:USP4 |
| Interaction | SOHLH1 interactions | 9.01e-05 | 115 | 184 | 7 | int:SOHLH1 | |
| Interaction | NELFB interactions | 9.01e-05 | 115 | 184 | 7 | int:NELFB | |
| Interaction | DUSP4 interactions | 1.06e-04 | 118 | 184 | 7 | int:DUSP4 | |
| Interaction | PNMA2 interactions | 1.08e-04 | 251 | 184 | 10 | int:PNMA2 | |
| GeneFamily | EF-hand domain containing|Plakins | 1.56e-05 | 8 | 120 | 3 | 939 | |
| GeneFamily | Tudor domain containing | 1.03e-04 | 37 | 120 | 4 | 780 | |
| GeneFamily | Mitogen-activated protein kinase kinase kinase kinases | 4.31e-04 | 5 | 120 | 2 | 655 | |
| GeneFamily | Peroxiredoxins | 6.44e-04 | 6 | 120 | 2 | 953 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 7.19e-04 | 161 | 120 | 6 | 593 | |
| GeneFamily | Potassium voltage-gated channels | 2.36e-03 | 40 | 120 | 3 | 274 | |
| ToppCell | 356C-Lymphocytic-NK_cells-NK_cell_A2|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 5.82e-08 | 176 | 186 | 9 | 052b54c4337ca728974a106b6dbd3b72dd28eb23 | |
| ToppCell | 356C-Lymphocytic-NK_cells-NK_cell_A2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 4.02e-07 | 161 | 186 | 8 | 8ec923c230a7a3cce5edf2a736b3a00d607c698a | |
| ToppCell | facs-Large_Intestine-Proximal-24m-Epithelial-secretory_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.93e-07 | 173 | 186 | 8 | 766e712e4db440468a32971459c1d3354add611f | |
| ToppCell | facs-Large_Intestine-Proximal-24m-Epithelial-Reg4/cKit+_deep_crypt_secretory_cells_(Distal)|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.93e-07 | 173 | 186 | 8 | 40ef91afb366e87b5ba2951d2578ebfe04d042c0 | |
| ToppCell | 390C-Lymphocytic-NK_cells-NK_cell_B1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.03e-06 | 126 | 186 | 7 | 10e1448a03f79965b72922fd83ef51de1b7b474f | |
| ToppCell | wk_15-18-Endothelial-Lymph_endothelial|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.77e-06 | 196 | 186 | 8 | ff627244d7f5fd6a2ec009dae32d3509f0e2d95e | |
| ToppCell | Ionocyte-iono-2|World / Class top | 8.42e-06 | 173 | 186 | 7 | e5ec28ccc5e048fd98de4c876e5c53b866b66228 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Lymphocytic-Epcam____thick_ascending_tube_S_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.05e-05 | 179 | 186 | 7 | 4166c4e1a8748a79ac6a11fd0b97c5344be2321b | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Neuronal-neurons_A-Branch_A4_(IN)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.17e-05 | 182 | 186 | 7 | be32b5b8153c1053cbb55f1fccfa27c3ee97c1e1 | |
| ToppCell | RA-11._Adipocyte|World / Chamber and Cluster_Paper | 1.44e-05 | 188 | 186 | 7 | 4dac9d636e5cad4cda540b93d4bfed6b5732c880 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.55e-05 | 190 | 186 | 7 | 876bd2eb9ed2624cb23bdcf6b989e4fa34d099e3 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex-lymphatic_endothelial_cell_of_renal_cortex|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.55e-05 | 190 | 186 | 7 | be9f36127028f52ca5fc1b32ba15a6c26aad69ac | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.55e-05 | 190 | 186 | 7 | 09a8855901c3c9332dbaab3e40166485b696d0f1 | |
| ToppCell | wk_15-18-Endothelial-Lymph_endothelial-Lymphatic_endo|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.77e-05 | 194 | 186 | 7 | bc03d0f8dca9f4ba10db2f2274293f8b119e8951 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.15e-05 | 200 | 186 | 7 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW10-Macroglial-Astrocyte|GW10 / Sample Type, Dataset, Time_group, and Cell type. | 2.15e-05 | 200 | 186 | 7 | 98a994692440cb4f505b050276f0c8022c814a21 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW10-Macroglial|GW10 / Sample Type, Dataset, Time_group, and Cell type. | 2.15e-05 | 200 | 186 | 7 | ef222dc4a205d670172dae74990bdb952ac92e5b | |
| ToppCell | 368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_6|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 4.66e-05 | 154 | 186 | 6 | ba55a63cfa5e0fb9dfec794f80078a2f0d03d0ad | |
| ToppCell | mild_COVID-19_(asymptomatic)-CD8+_T_naive|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2) | 4.83e-05 | 155 | 186 | 6 | e2c901d5c9e42d25d7702e5e8fc19b06f7c817be | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Lymphocytic-Epcam____proximal_tube_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.37e-05 | 158 | 186 | 6 | 1d78578dc1f8ba43dacdccae1082c0b9d749f64d | |
| ToppCell | Influenza_Severe-pDC|World / Disease group and Cell class | 7.06e-05 | 166 | 186 | 6 | bd25ce4c03c3d6cd9d986b9be1d355da52f0f2d7 | |
| ToppCell | LV-11._Adipocyte|World / Chamber and Cluster_Paper | 7.06e-05 | 166 | 186 | 6 | 7e5852891714465c6228c9f955fd511ec79d0e02 | |
| ToppCell | Adult-Mesenchymal-chondrocyte-D175|Adult / Lineage, Cell type, age group and donor | 7.55e-05 | 168 | 186 | 6 | 14071b961c9bdb54a8259b12a88237b802cbde36 | |
| ToppCell | COVID-19_Moderate-NK_CD56bright|World / disease group, cell group and cell class | 8.06e-05 | 170 | 186 | 6 | caa6a534c1e9639caced9a51680f5c905f061bcc | |
| ToppCell | 368C-Myeloid-Macrophage-FABP4+_Macrophage_2|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 8.32e-05 | 171 | 186 | 6 | e59afa0a773dca3b9c208d17510ea55703b42598 | |
| ToppCell | COVID-19_Moderate-NK_CD56bright|COVID-19_Moderate / disease group, cell group and cell class | 8.87e-05 | 173 | 186 | 6 | a07dcb1e555caaa2235aec219334fcbf2d07f10c | |
| ToppCell | 3'_v3-lymph-node_spleen-Hematopoietic_progenitors-Progenitor_MEMP|lymph-node_spleen / Manually curated celltypes from each tissue | 9.75e-05 | 176 | 186 | 6 | 23a8ec42ebd42c539865a12d09773af90f3f8848 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma|TCGA-Brain / Sample_Type by Project: Shred V9 | 1.01e-04 | 177 | 186 | 6 | e8ab340b20cd41554c3841fe980e078e878af35f | |
| ToppCell | RV-11._Adipocyte|RV / Chamber and Cluster_Paper | 1.04e-04 | 178 | 186 | 6 | 278bbea5cf8f0589f71675c7a3d00679391b5253 | |
| ToppCell | PCW_10-12-Endothelial-Endothelial_mature-lymphatic|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.07e-04 | 179 | 186 | 6 | ab3d08b51cd7a37582305615ee221c7a2af83b40 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_STON2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.07e-04 | 179 | 186 | 6 | d1365d48d1b017a7917f4f63a82ac4720c3d87df | |
| ToppCell | PCW_10-12-Endothelial-Endothelial_mature-lymphatic-endo_lymphatic_(7)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.07e-04 | 179 | 186 | 6 | 35fe9961e228ce255e3317fc244efa35b5adbf8b | |
| ToppCell | RA-11._Adipocyte|RA / Chamber and Cluster_Paper | 1.10e-04 | 180 | 186 | 6 | d48a3d27357f7d184132a6805950f93080146b59 | |
| ToppCell | facs-Marrow-B-cells-18m-Hematologic-MPP_Fraction_B_+_C|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-04 | 180 | 186 | 6 | 7368ab31c3273374ef260f0d710d4eea83cbc4a2 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.14e-04 | 181 | 186 | 6 | e898ecb8d8f2eb2204225b7b0d665cadcd241139 | |
| ToppCell | 343B-Lymphocytic-NK_cells-Proliferating_NK_cell|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.17e-04 | 182 | 186 | 6 | b1e66ccd5f33b4801f1cafddf97f5fc0c6dba8d1 | |
| ToppCell | LA-11._Adipocyte|World / Chamber and Cluster_Paper | 1.21e-04 | 183 | 186 | 6 | b177be283e1553fb1f69a346f1ba79ad00297fa2 | |
| ToppCell | LA-11._Adipocyte|LA / Chamber and Cluster_Paper | 1.21e-04 | 183 | 186 | 6 | 3f9011976782fa8aa95cdd6f00f07a91094d411b | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_STON2|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.21e-04 | 183 | 186 | 6 | 5a541a7f6c3514be8a13e988185dfe388c874f8b | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_prolif|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.24e-04 | 184 | 186 | 6 | a6dee97ee4ef9d89e11d17339e0dadaea1210ce5 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.24e-04 | 184 | 186 | 6 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.24e-04 | 184 | 186 | 6 | 2ba98708dfd7f1b2a661578a334684094ff453ad | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.24e-04 | 184 | 186 | 6 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.24e-04 | 184 | 186 | 6 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | COVID-19-Neuronal_cells-Neuronal_cells|COVID-19 / group, cell type (main and fine annotations) | 1.28e-04 | 185 | 186 | 6 | 4a095829992b39856a73bdfac03ee68b9aa0d3b8 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L1-3_PVALB_WFDC2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.28e-04 | 185 | 186 | 6 | e87e6e097dc29ece8aea671935bde281b99b93ea | |
| ToppCell | PCW_13-14-Endothelial-Endothelial_mature-lymphatic-endo_lymphatic_(7)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.28e-04 | 185 | 186 | 6 | 3be9e05b929ac4d956b1d53284072f668a6c1959 | |
| ToppCell | COVID-19-Neuronal_cells|COVID-19 / group, cell type (main and fine annotations) | 1.28e-04 | 185 | 186 | 6 | 36ce23893915f5c380cca39b2c33a516edf31c3a | |
| ToppCell | PCW_13-14-Endothelial-Endothelial_mature-lymphatic|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.28e-04 | 185 | 186 | 6 | c3dd64a726cb8a1fe048683c266b7532a714a52e | |
| ToppCell | healthy_donor-Lymphocytic-Dendritic|healthy_donor / Disease condition, Lineage, Cell class and subclass | 1.32e-04 | 186 | 186 | 6 | 916f2aeea4989ba7a29e071e348a51010f010223 | |
| ToppCell | healthy_donor-Lymphocytic-Dendritic-pDC|healthy_donor / Disease condition, Lineage, Cell class and subclass | 1.32e-04 | 186 | 186 | 6 | 45f66619e45d590c7365a51782d4ac46b7d31fde | |
| ToppCell | tumor_Lung-Endothelial_cells-Lymphatic_ECs|tumor_Lung / Location, Cell class and cell subclass | 1.36e-04 | 187 | 186 | 6 | 87ecdc5f24aced95a37e653429f0fc493ff4aa3e | |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | 1.36e-04 | 187 | 186 | 6 | 92d468dde81125d51daf7abd4703741abe1ab91c | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Neuronal-neurons_A-Branch_A3_(IPAN/IN)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.40e-04 | 188 | 186 | 6 | bd091503f580dedab40e0996273101285d24b586 | |
| ToppCell | Ciliated_cells-B-Donor_07|World / lung cells shred on cell class, cell subclass, sample id | 1.40e-04 | 188 | 186 | 6 | 606907c865bd2f11bb6474932716550f7723d858 | |
| ToppCell | droplet-Lung-18m-Epithelial-airway_epithelial-lung_ciliated_cell-ciliated_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.40e-04 | 188 | 186 | 6 | 0eca3dc93724e23b71e687fc24fa9f1e89bdef6a | |
| ToppCell | droplet-Lung-18m-Epithelial-airway_epithelial-lung_ciliated_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.40e-04 | 188 | 186 | 6 | 9ce3e1fffce87ad19812ecbf9b7f9935a975d676 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM2_(12)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.40e-04 | 188 | 186 | 6 | 3004e961d214919e08c7cd5f10c3de5cf85b35a3 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.44e-04 | 189 | 186 | 6 | 78cf414b98bcb19deb934409acddaad1cd51b67f | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_myocytic-mes_ASM_(13)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.44e-04 | 189 | 186 | 6 | da9ecc0d7b81c1901f30f97bb44112dc85444a66 | |
| ToppCell | droplet-Lung-18m-Epithelial-airway_epithelial|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.44e-04 | 189 | 186 | 6 | fe958fdf9963c2dfe270f67f0da36b3264d0017c | |
| ToppCell | Control-Myeloid-pDC|Control / Disease group, lineage and cell class | 1.44e-04 | 189 | 186 | 6 | 46770b99da42f11f10cfc67cea8562342d60b867 | |
| ToppCell | PBMC-Control-Myeloid-pDC|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.48e-04 | 190 | 186 | 6 | adffa93635da10251f28b2089fd96b189775c8b4 | |
| ToppCell | PBMC-Control-Myeloid-pDC-pDC|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.48e-04 | 190 | 186 | 6 | 9a91bf1ea105029e6412d0d9060bca325299ce26 | |
| ToppCell | PBMC-Control-Myeloid-pDC-pDC|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.48e-04 | 190 | 186 | 6 | 39c8ddc2639bf3e986dae11fbae61a735614b604 | |
| ToppCell | PBMC-Control-Myeloid-pDC|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.48e-04 | 190 | 186 | 6 | 2c1c079fd411c03bc3f383aa927eea9446716960 | |
| ToppCell | myeloid-pDC|World / Lineage and Cell class | 1.48e-04 | 190 | 186 | 6 | 88c42779ce2f817d28e672d83f3f1158581edf73 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.48e-04 | 190 | 186 | 6 | 3f22c118d552345f731d4d49f0bcb5765d93de3b | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.48e-04 | 190 | 186 | 6 | 39ab890104b4264c68a968f920f4ccd84f0bc681 | |
| ToppCell | PBMC-Control-Myeloid-pDC-pDC-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.48e-04 | 190 | 186 | 6 | a95aea3aa707fc4574810706341a5f32b3d00209 | |
| ToppCell | PBMC-Control-Myeloid-pDC-pDC-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.48e-04 | 190 | 186 | 6 | 18dfa84c62dcf081ce9958a71e76a394ec0968e4 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.48e-04 | 190 | 186 | 6 | 0acf1d5da68db449d8c9e70519a236ce825f9d11 | |
| ToppCell | 15-Trachea-Epithelial-Neuroendocrine|Trachea / Age, Tissue, Lineage and Cell class | 1.52e-04 | 191 | 186 | 6 | 76311fa5f3ae9bb27cf04387a8c92300f2888c28 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Macroglial-astrocyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.52e-04 | 191 | 186 | 6 | fd345837bfc40d85256b9a7e4fd3343bcbfe0ae5 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.52e-04 | 191 | 186 | 6 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.57e-04 | 192 | 186 | 6 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | severe-low-quality_cells|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.61e-04 | 193 | 186 | 6 | 9337bc93e3904c7fc7c93c328518bcd6453b1e8c | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.61e-04 | 193 | 186 | 6 | b3ad5ff480d99217f36cc7471e5a96a519ddb409 | |
| ToppCell | VE-pDC-|VE / Condition, Cell_class and T cell subcluster | 1.61e-04 | 193 | 186 | 6 | 583724de588fcde3aeda056138c522dc0225a387 | |
| ToppCell | VE-pDC|VE / Condition, Cell_class and T cell subcluster | 1.61e-04 | 193 | 186 | 6 | bb759dc9ef0ec41d655002f59021d62d62d44289 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.70e-04 | 195 | 186 | 6 | 481989d2e5bd2582da3d86b0155c4d6615317067 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.70e-04 | 195 | 186 | 6 | 6108a27523d1b93a7fbe35cb95704a5ad9071e3c | |
| ToppCell | facs-Large_Intestine-Distal-18m-Epithelial-intestinal_crypt_stem_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.70e-04 | 195 | 186 | 6 | 44ac99e33b20a377009b8fef16142050a3e1da51 | |
| ToppCell | COVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations) | 1.70e-04 | 195 | 186 | 6 | 603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7 | |
| ToppCell | Sepsis-Bac-SEP-Lymphocyte-B-B_intermediate|Bac-SEP / Disease, condition lineage and cell class | 1.75e-04 | 196 | 186 | 6 | 1611920211beb1a3691e3853e0314792a74279a0 | |
| ToppCell | (08)_PNEC|World / shred by cell type and Timepoint | 1.75e-04 | 196 | 186 | 6 | 2ee37155c03cd5009427a4bffe6c80ed2ac6939e | |
| ToppCell | moderate-Lymphoid-Treg|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.75e-04 | 196 | 186 | 6 | 9152f4a8a27ff4ee28f231c5ad00eb2edd9ea6da | |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.75e-04 | 196 | 186 | 6 | 9830fb3da7a60f65ad463e9054bb77c06b025e4d | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.75e-04 | 196 | 186 | 6 | 7d8505dac15fa59935ccf592afc54b04c4c6554f | |
| ToppCell | Parenchyma_Control_(B.)-Immune-TX-MoAM-4|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 1.80e-04 | 197 | 186 | 6 | dc1c55e3aacc9d60d0f111c2f20f150ca296f011 | |
| ToppCell | wk_15-18-Mesenchymal-Fibroblast-Early_fibro|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.85e-04 | 198 | 186 | 6 | ecf0a8f2e07f336e23b6f32a2c48d3c7eb66572b | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-3.5_mon-Neuronal-IN_Progenitors|3.5_mon / Sample Type, Dataset, Time_group, and Cell type. | 1.85e-04 | 198 | 186 | 6 | 3811d9e3e54bbe8b208c591697e43b55ab5bbf0e | |
| ToppCell | Parenchymal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.85e-04 | 198 | 186 | 6 | d1827e3707b929e3a3562989a0c11537d344e164 | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.85e-04 | 198 | 186 | 6 | cc2b5b632e73e44bb60050f0db10d8f0dbb859fa | |
| ToppCell | nucseq-Mesenchymal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.85e-04 | 198 | 186 | 6 | 8f52243ca8b9ba68a75ae411506a3a6de258eb97 | |
| ToppCell | Sepsis-ICU-SEP-Myeloid-pDC|ICU-SEP / Disease, condition lineage and cell class | 1.85e-04 | 198 | 186 | 6 | fe8a68bff8c1b9566eee4bfcab564f206a20ae7b | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Neuronal-neurons_A|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.85e-04 | 198 | 186 | 6 | 800ade4261695f2efd869d2b1243571de963c431 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_low-phase|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.86e-04 | 126 | 186 | 5 | 8ae631694bbba40f64e55e2be8162d7a40eeadc5 | |
| ToppCell | Parenchyma_COVID-19-Endothelial-TX-Lymphatic|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 1.90e-04 | 199 | 186 | 6 | 88f33b8dcd837abfa1d12c28719e073a7da6e979 | |
| ToppCell | Lung_Parenchyma-Severe-Endothelial-Endothelial-Lymphatic|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.90e-04 | 199 | 186 | 6 | 64b19aff72e2a109cb5857cb248bd4712dd49b43 | |
| Disease | ciliopathy (implicated_via_orthology) | 3.75e-06 | 40 | 174 | 5 | DOID:0060340 (implicated_via_orthology) | |
| Disease | Goiter | 6.93e-06 | 7 | 174 | 3 | C0018021 | |
| Disease | epilepsy (implicated_via_orthology) | 5.40e-05 | 163 | 174 | 7 | DOID:1826 (implicated_via_orthology) | |
| Disease | Inherited neuropathies | 9.04e-05 | 40 | 174 | 4 | C0598589 | |
| Disease | short QT syndrome (implicated_via_orthology) | 1.03e-04 | 3 | 174 | 2 | DOID:0050793 (implicated_via_orthology) | |
| Disease | autosomal recessive spinocerebellar ataxia 4 (implicated_via_orthology) | 1.03e-04 | 3 | 174 | 2 | DOID:0111611 (implicated_via_orthology) | |
| Disease | sporadic breast cancer (is_implicated_in) | 2.06e-04 | 4 | 174 | 2 | DOID:8029 (is_implicated_in) | |
| Disease | Joubert syndrome 1 | 2.48e-04 | 21 | 174 | 3 | C4551568 | |
| Disease | blood pressure | 2.86e-04 | 22 | 174 | 3 | EFO_0004325 | |
| Disease | free cholesterol measurement, very low density lipoprotein cholesterol measurement | 3.00e-04 | 215 | 174 | 7 | EFO_0008317, EFO_0008591 | |
| Disease | fasting blood glucose measurement, glucose tolerance test, fasting blood insulin measurement | 3.42e-04 | 5 | 174 | 2 | EFO_0004307, EFO_0004465, EFO_0004466 | |
| Disease | X-24020 measurement | 3.42e-04 | 5 | 174 | 2 | EFO_0022128 | |
| Disease | Pituitary-dependent Cushing's disease | 3.42e-04 | 5 | 174 | 2 | C0221406 | |
| Disease | alkaline phosphatase measurement | TDRD15 SLC4A8 ACACB TRIP6 ENPP3 SLC26A4 DHX38 GATC PPARG SLC1A3 CRMP1 MAP4K5 MACF1 NUP160 MAP4K2 GABBR1 | 3.55e-04 | 1015 | 174 | 16 | EFO_0004533 |
| Disease | triglyceride measurement, very low density lipoprotein cholesterol measurement | 3.84e-04 | 224 | 174 | 7 | EFO_0004530, EFO_0008317 | |
| Disease | triglycerides:total lipids ratio, very low density lipoprotein cholesterol measurement | 3.95e-04 | 225 | 174 | 7 | EFO_0008317, EFO_0020947 | |
| Disease | Ciliopathies | 5.00e-04 | 110 | 174 | 5 | C4277690 | |
| Disease | Prolactinoma | 5.11e-04 | 6 | 174 | 2 | C0033375 | |
| Disease | episodic ataxia type 6 (implicated_via_orthology) | 5.11e-04 | 6 | 174 | 2 | DOID:0050994 (implicated_via_orthology) | |
| Disease | glucose tolerance test | 5.31e-04 | 27 | 174 | 3 | EFO_0004307 | |
| Disease | high density lipoprotein particle size measurement | 5.33e-04 | 170 | 174 | 6 | EFO_0008592 | |
| Disease | total lipids in very large HDL measurement | 6.33e-04 | 66 | 174 | 4 | EFO_0022312 | |
| Disease | epididymis-specific alpha-mannosidase measurement | 7.12e-04 | 7 | 174 | 2 | EFO_0801577 | |
| Disease | Familial aplasia of the vermis | 7.28e-04 | 30 | 174 | 3 | C0431399 | |
| Disease | cholesterol in very large HDL measurement | 7.49e-04 | 69 | 174 | 4 | EFO_0022229 | |
| Disease | Schizophrenia | DRD1 NFASC SLC1A3 SLC1A6 PRDX6 CRMP1 PHB1 KCNH6 SETDB1 PPP3CC KCNH2 UNC5C HSPA9 GABBR1 | 7.87e-04 | 883 | 174 | 14 | C0036341 |
| Disease | fatty liver disease (implicated_via_orthology) | 8.02e-04 | 31 | 174 | 3 | DOID:9452 (implicated_via_orthology) | |
| Disease | angina pectoris | 8.93e-04 | 125 | 174 | 5 | EFO_0003913 | |
| Disease | Meckel syndrome (implicated_via_orthology) | 9.46e-04 | 8 | 174 | 2 | DOID:0050778 (implicated_via_orthology) | |
| Disease | glucose metabolism decline measurement, cingulate cortex measurement | 1.21e-03 | 9 | 174 | 2 | EFO_0007738, EFO_0009392 | |
| Disease | low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | 1.24e-03 | 200 | 174 | 6 | EFO_0004611, EFO_0020945 | |
| Disease | leptin measurement | 1.36e-03 | 81 | 174 | 4 | EFO_0005000 | |
| Disease | Meckel-Gruber syndrome | 1.51e-03 | 10 | 174 | 2 | cv:C0265215 | |
| Disease | long QT syndrome (implicated_via_orthology) | 1.51e-03 | 10 | 174 | 2 | DOID:2843 (implicated_via_orthology) | |
| Disease | very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 1.77e-03 | 291 | 174 | 7 | EFO_0008317, EFO_0020946 | |
| Disease | Pancreatic Ductal Adenocarcinoma | 1.84e-03 | 11 | 174 | 2 | C1335302 | |
| Disease | Bipolar Disorder | 2.19e-03 | 477 | 174 | 9 | C0005586 | |
| Disease | Abruptio Placentae | 2.19e-03 | 12 | 174 | 2 | EFO_1001754 | |
| Disease | free cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement | 2.22e-03 | 303 | 174 | 7 | EFO_0004612, EFO_0020945 | |
| Disease | schizophrenia (is_marker_for) | 2.23e-03 | 44 | 174 | 3 | DOID:5419 (is_marker_for) | |
| Disease | phospholipids:total lipids ratio | 2.35e-03 | 227 | 174 | 6 | EFO_0020946 | |
| Disease | cholesterol to total lipids in large VLDL percentage | 2.38e-03 | 45 | 174 | 3 | EFO_0022236 | |
| Disease | sexual dimorphism measurement | RANBP10 EPPK1 PHF20 DNAH10 RBL1 POLR2A PRAM1 SETDB1 KCNH2 BTN1A1 AHCY MACF1 PATJ DNA2 BANK1 | 2.40e-03 | 1106 | 174 | 15 | EFO_0021796 |
| Disease | Parkinson's disease (implicated_via_orthology) | 2.44e-03 | 157 | 174 | 5 | DOID:14330 (implicated_via_orthology) | |
| Disease | very low density lipoprotein cholesterol measurement, phospholipid measurement | 2.45e-03 | 229 | 174 | 6 | EFO_0004639, EFO_0008317 | |
| Disease | Bardet-Biedl Syndrome | 2.58e-03 | 13 | 174 | 2 | C0752166 | |
| Disease | Nephronophthisis | 2.58e-03 | 13 | 174 | 2 | C0687120 | |
| Disease | free cholesterol measurement, high density lipoprotein cholesterol measurement | 2.75e-03 | 315 | 174 | 7 | EFO_0004612, EFO_0008591 | |
| Disease | total lipids in lipoprotein particles measurement | 2.87e-03 | 48 | 174 | 3 | EFO_0022309 | |
| Disease | systemic lupus erythematosus | CDH23 PPARG ACOX2 PHB1 MELTF SORCS2 CERCAM NEURL4 TNPO3 BANK1 GABBR1 ANKRD16 | 2.89e-03 | 799 | 174 | 12 | MONDO_0007915 |
| Disease | Bardet-Biedl syndrome (is_implicated_in) | 3.00e-03 | 14 | 174 | 2 | DOID:1935 (is_implicated_in) | |
| Disease | urinary bladder cancer (biomarker_via_orthology) | 3.00e-03 | 14 | 174 | 2 | DOID:11054 (biomarker_via_orthology) | |
| Disease | very low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | 3.03e-03 | 239 | 174 | 6 | EFO_0008317, EFO_0020945 | |
| Disease | triglyceride measurement, low density lipoprotein cholesterol measurement | 3.10e-03 | 166 | 174 | 5 | EFO_0004530, EFO_0004611 | |
| Disease | cholesteryl esters to total lipids in IDL percentage | 3.22e-03 | 50 | 174 | 3 | EFO_0022247 | |
| Disease | cholesteryl esters:total lipids ratio, high density lipoprotein cholesterol measurement | 3.29e-03 | 243 | 174 | 6 | EFO_0004612, EFO_0020944 | |
| Disease | Nonsyndromic Hearing Loss and Deafness, Autosomal Recessive | 3.41e-03 | 51 | 174 | 3 | cv:CN043650 | |
| Disease | Meckel-Gruber syndrome | 3.45e-03 | 15 | 174 | 2 | C0265215 | |
| Disease | anemia (implicated_via_orthology) | 3.45e-03 | 15 | 174 | 2 | DOID:2355 (implicated_via_orthology) | |
| Disease | lipid measurement, high density lipoprotein cholesterol measurement | 3.56e-03 | 330 | 174 | 7 | EFO_0004529, EFO_0004612 | |
| Disease | chylomicron measurement, very low density lipoprotein cholesterol measurement | 3.64e-03 | 106 | 174 | 4 | EFO_0008317, EFO_0008596 | |
| Disease | Barrett Epithelium | 3.93e-03 | 16 | 174 | 2 | C1258085 | |
| Disease | Barrett Esophagus | 3.93e-03 | 16 | 174 | 2 | C0004763 | |
| Disease | Epilepsy | 4.02e-03 | 109 | 174 | 4 | C0014544 | |
| Disease | Drugs used in diabetes use measurement | 4.15e-03 | 255 | 174 | 6 | EFO_0009924 | |
| Disease | triglycerides in medium VLDL measurement | 4.22e-03 | 55 | 174 | 3 | EFO_0022155 | |
| Disease | IGF-1 measurement, IGFBP-3 measurement | 4.44e-03 | 17 | 174 | 2 | EFO_0004626, EFO_0004627 | |
| Disease | free cholesterol to total lipids in large HDL percentage | 4.44e-03 | 56 | 174 | 3 | EFO_0022279 | |
| Disease | bilirubin measurement | 4.88e-03 | 442 | 174 | 8 | EFO_0004570 | |
| Disease | Meckel syndrome type 1 | 4.97e-03 | 18 | 174 | 2 | C3714506 | |
| Disease | BMI-adjusted fasting blood insulin measurement | 4.97e-03 | 18 | 174 | 2 | EFO_0008037 | |
| Disease | Bardet-Biedl syndrome | 4.97e-03 | 18 | 174 | 2 | cv:C0752166 | |
| Disease | severe acute respiratory syndrome, COVID-19 | 5.21e-03 | 447 | 174 | 8 | EFO_0000694, MONDO_0100096 | |
| Disease | cholesterol to total lipids in IDL percentage | 5.39e-03 | 60 | 174 | 3 | EFO_0022233 | |
| Disease | ferritin measurement | 5.48e-03 | 119 | 174 | 4 | EFO_0004459 | |
| Disease | Hypertriglyceridemia | 5.53e-03 | 19 | 174 | 2 | EFO_0004211 | |
| Disease | triglyceride measurement, body mass index | 5.53e-03 | 19 | 174 | 2 | EFO_0004340, EFO_0004530 | |
| Disease | triglycerides in small VLDL measurement | 5.65e-03 | 61 | 174 | 3 | EFO_0022145 | |
| Disease | free cholesterol in very large VLDL measurement | 5.65e-03 | 61 | 174 | 3 | EFO_0022274 | |
| Disease | cholesterol:total lipids ratio, intermediate density lipoprotein measurement | 5.81e-03 | 121 | 174 | 4 | EFO_0008595, EFO_0020943 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| FAREDRTVGLAVLQL | 1626 | Q9UPW8 | |
| LETVERLGEAVRTEL | 141 | Q9H313 | |
| VNRDLSIRGIDISVF | 131 | Q4AC99 | |
| GEIFIILRDEVIGDT | 211 | Q8NDB2 | |
| VELLAVGLETFNRAR | 621 | Q9HCE0 | |
| LRRVIEGELVINSAF | 1251 | Q9HCE0 | |
| VFVRALRSLGSEEQI | 121 | Q99424 | |
| RFLVSELGVDVDVRA | 256 | Q6P6B7 | |
| TLGEEVDGRRLVVAT | 1821 | Q9NR09 | |
| AIIRLLVEDGTAEAV | 1071 | Q2NKJ3 | |
| VGERVFAAESIIKRR | 6 | O95503 | |
| FANTVGLVVERRRLE | 96 | P46952 | |
| EEGLFTVAASVIIRD | 196 | Q13410 | |
| DTIGVAVDLILLFRE | 106 | Q9UBB4 | |
| VLVGEFAQIREEREI | 371 | Q96DY2 | |
| VRLAVTRLEGVDEAT | 326 | P22570 | |
| FVEVARSRDIEVLEG | 1276 | P16157 | |
| QLSFRRGDIIEVLER | 176 | Q13588 | |
| FERVEGISRATIIDL | 166 | Q96DB2 | |
| VLRVQAAGTDEVRVF | 66 | A6NE02 | |
| VRFGRILEDLDSLGV | 111 | Q9Y305 | |
| EASREGVVEIVRGIL | 191 | Q9NU02 | |
| LVDRVLERFQASGLI | 281 | Q8N9N2 | |
| EAVGREAVRLLVSVD | 286 | Q8WXF8 | |
| GTGLVVERDFSVRIL | 11 | P21728 | |
| LRAFTTELVVEAVVR | 26 | O60826 | |
| IRVLRAGAFDDLTEL | 111 | O15335 | |
| IGEVFVARPLDREEL | 1476 | Q9H251 | |
| RGDLIIEFEVIFPER | 311 | P25685 | |
| LGVIALDVAEREARV | 486 | Q6UXK2 | |
| AVIFDRFRGVQDIVV | 36 | P35232 | |
| VARFDAGELITQREL | 131 | P35232 | |
| AATERIILFGRELQA | 506 | Q6VN20 | |
| TVFVGNLEARVREEI | 11 | P57052 | |
| VFIDSGGVRRVAELL | 21 | Q5T6V5 | |
| VALFTIRDRDIRVGG | 366 | Q9Y5F3 | |
| LEIGELAVRGARVVS | 56 | Q9Y5E7 | |
| QEITDETRIFRVLGA | 776 | Q12851 | |
| ETRIFRVLGAHRDII | 781 | Q12851 | |
| IDDVVRLFAAELGRE | 16 | O00255 | |
| RDVIVIGNDITFRIG | 1786 | O00763 | |
| VDVLVFVVDSADRLR | 146 | Q8N8L6 | |
| VLSELRAEDAGEVRF | 1776 | O75147 | |
| EEDTFIRTVELLGAV | 856 | Q7RTW8 | |
| VTDDFGRVILLDVAR | 401 | Q9H2M9 | |
| ERRVVTVVFLGLLLD | 21 | Q14728 | |
| FIVVAILRIRSAEGR | 221 | Q8NGI7 | |
| LFTGVVDARGERAVL | 1896 | Q14676 | |
| ERLALVDFGSREAVA | 41 | O43716 | |
| VREVIARIVDGSRFT | 331 | Q9HCC0 | |
| ITALERERGVEVRFV | 56 | Q9NVR5 | |
| RLIRETEATFRGLVE | 76 | Q8N158 | |
| LEVVERATRFLRSVV | 251 | O95714 | |
| VVADFGLSRLIVEER | 466 | P53671 | |
| LEERVKEAGIEITFR | 326 | Q9UBS5 | |
| VVTIRLDRAESIAGL | 1296 | O60303 | |
| EVRGFLRVAVQAIAA | 1001 | O60333 | |
| FISRGSIEILRGDVV | 781 | Q12809 | |
| RGSIEILRDDVVVAI | 636 | Q9H252 | |
| VEFARAGLTEPVLIR | 286 | Q8TDD1 | |
| SAIVLDQFVRLRDGD | 501 | Q9NRD8 | |
| SSVLEFRVRDIGELV | 236 | Q86V42 | |
| ASIGFIVVIDRRRDK | 96 | Q86YR7 | |
| VTIRGENLGLEFRDI | 876 | Q9HCM2 | |
| DLVVQRLGFDTRVTV | 281 | P17858 | |
| IQDADRVIRGFEATL | 641 | Q92817 | |
| RIGLETEAQFTAVER | 1096 | Q96J66 | |
| SVREAAVELLGRFVL | 1826 | Q6KC79 | |
| IERAALDGSDRVVLV | 471 | O75581 | |
| SLRRLEVGDNDLVFV | 151 | P0C6S8 | |
| ARFVILRVLLEAGEG | 571 | Q9NY33 | |
| DGRITIREFFILLQV | 1891 | Q8NG31 | |
| FRARLATVGDLEEIQ | 1696 | Q96RT7 | |
| SIVSFRQLREEVLGE | 366 | Q96RR1 | |
| GLYVIEVTRDVIVRA | 1261 | Q9Y5S2 | |
| LTRAQFEGIVTDLIR | 346 | P38646 | |
| VGEIRREIVSGLLAA | 1231 | P28290 | |
| EQAFEVAERLGVTRL | 256 | Q9UPN3 | |
| IQEVFTLRVLVRDGG | 1791 | Q6V1P9 | |
| FVRELLLRGTEVILA | 636 | Q9NVE7 | |
| ALVRERGADLVVIEG | 711 | Q9NVE7 | |
| RISFNLGAAEEVERL | 76 | Q9C0D0 | |
| REVAGDTIIFRDTQI | 386 | O94856 | |
| LDGTISVVFEERLRQ | 341 | Q9BTY2 | |
| NLLERVGFEEVIVVT | 41 | Q9NR50 | |
| KVLFVGESDIRERRA | 96 | Q53T59 | |
| EVGTALQEFREVRLI | 1121 | Q9BZ29 | |
| FRLLEEETLIDGVRV | 371 | Q9Y6A2 | |
| IARVRDVELLTGLDF | 836 | O14638 | |
| IVRVTAADAFLDLIR | 161 | P43003 | |
| RIIEIEGNRLTSAFI | 311 | Q12934 | |
| VIRLIGRDTVEEIVY | 466 | Q86WJ1 | |
| LVGFVLRRDLIISIE | 701 | P51795 | |
| LQGDRVRDTFLDVLL | 826 | Q86WZ0 | |
| LEEGLGVDRRITRFV | 401 | P48664 | |
| RDLDVVVVSVAGAFR | 56 | Q6DD88 | |
| AVEALLRAVFGVVVD | 16 | Q9Y600 | |
| VRQLLEEGRLEFVIG | 96 | Q9Y2E5 | |
| DLGTFRDQAIVRVAV | 371 | Q9UJ99 | |
| FLVGERVTLADITVV | 151 | P26641 | |
| EVVARGLARVLVFED | 401 | Q5T4B2 | |
| GLARVLVFEDDVRFE | 406 | Q5T4B2 | |
| DRVIVSGEERSLFAL | 516 | P51530 | |
| IVDSFIRGSILEARE | 1751 | Q8IVF4 | |
| DFTIEVERALRVLDG | 126 | Q96RP9 | |
| DIDRILRAGFTLQEA | 576 | Q92681 | |
| LRLGIFRQVDVLIDT | 91 | Q9Y512 | |
| ALRGFGARVIITEID | 231 | P23526 | |
| ERAIEERRVVFIGKI | 1536 | Q5VV67 | |
| LEAEAVFRAITIAGR | 231 | Q14194 | |
| ISNRALRDGELFEIV | 751 | Q96JN8 | |
| LLDVDFAEGVLRRTE | 241 | Q6VVB1 | |
| GFLLVTRALDREEQA | 76 | O75309 | |
| DETRVFRLLGSDRVV | 806 | Q9Y4K4 | |
| FRIEEIAEGREEAVL | 796 | Q13615 | |
| LRFIAELTIVGIFTD | 266 | Q9HAU5 | |
| VIFIRERSSGRLVID | 1556 | Q16363 | |
| ISFEVGAQLEARDRL | 11 | Q9BVI0 | |
| RIFLVDAVSGRENDL | 441 | Q5HYA8 | |
| VSFRGRILVEIAVEI | 391 | Q2WGJ9 | |
| RRGEVLRVITTVDED | 866 | Q9BVN2 | |
| RRGDVTFLEDVLNEI | 386 | Q5T160 | |
| REALEVAVAGTELFR | 386 | Q9NYH9 | |
| VFLGALREDVVVEQE | 126 | A6NEV1 | |
| VGRSVDETLRLVQAF | 221 | Q13162 | |
| DFLRELVITIAREGL | 136 | Q9NWS0 | |
| VVVRADTDGGLIFRL | 281 | P08582 | |
| LGRLVDGDSFRLIVE | 181 | B5MCY1 | |
| GRAVLDVTDRLAVLV | 896 | Q6ZUX3 | |
| VIEVVIRSEEGLSRD | 536 | P28749 | |
| LAFVVRIERIDGVSL | 96 | Q6DKI1 | |
| IFVITGVLESIERDE | 411 | P35251 | |
| VEFIDEGRTGLVTRD | 966 | Q587J7 | |
| GERVGRIVLELFADI | 26 | Q08752 | |
| ATTGRNFDEILRVVI | 151 | P30041 | |
| VFLGAVREDVVVELE | 126 | Q6ZRT6 | |
| DLAIFIAVIILSGDR | 411 | P37231 | |
| RALEAEQVEITVGRF | 2101 | P58107 | |
| LREGRELTDGVIATF | 2176 | Q8IVL1 | |
| RRGEILEVIEFTSNE | 611 | Q96QH2 | |
| AVAVRPGEDVLFVVR | 791 | Q96PQ0 | |
| VELFLADVEGLSVLR | 821 | Q15858 | |
| IVFRALGFVSDRDIL | 271 | P30876 | |
| EFDRQAEITRLLLEG | 201 | Q9Y371 | |
| GEGILSERRFEDSVI | 86 | O95785 | |
| GEVDILDRPIVAFVR | 306 | Q2Y0W8 | |
| IRSIFGNAVSRELIE | 216 | P40692 | |
| VRGNDTFVTLDEILR | 31 | P49959 | |
| ERRTDIFGVEETAIG | 471 | Q15459 | |
| EVVGIIESRARAVDL | 1061 | Q12769 | |
| LFEQLVRRVEILSEG | 11 | Q9H0H5 | |
| LERALVEVLGAERFS | 171 | Q8TAY7 | |
| RVEEVDGSLVRILFL | 366 | Q15047 | |
| ATVEAVEAREAIRGF | 441 | P48454 | |
| GQEETVRIVALDRSF | 411 | Q15654 | |
| PVELGTVAELRRFFI | 436 | Q9NXB0 | |
| EARGEIDFRDIIVIV | 191 | O15394 | |
| FTRLLEDVEVLEGRA | 1066 | Q15772 | |
| SFLDVVGVRSLRVIV | 666 | O43511 | |
| IAVVRRTDFLEATGL | 421 | O94991 | |
| FLRIAETRVGDAVLG | 191 | Q86WA9 | |
| TRLVREGFNVGIVVD | 646 | Q9Y2P5 | |
| RSVIVIRSLVADGVA | 711 | Q8NI35 | |
| IEGRVVEISRLQEIF | 256 | Q9P2W9 | |
| DVIRINGRDVVLATF | 301 | Q9H2E6 | |
| IGVRLIEDFLARSNV | 51 | O43617 | |
| DIVEIFTVLGIEAVR | 1361 | P24928 | |
| VGELEFLDRTVVAFV | 336 | Q6U841 | |
| TILVDGVSEEFRLVD | 996 | Q92752 | |
| RELFFRDIERGDIVI | 116 | Q96N46 | |
| RVLIGFEEDILIVSE | 46 | Q9Y5W5 | |
| DGRQRVLLFTDDVAL | 3056 | Q709C8 | |
| LTEIEEEVGRLFRTN | 256 | Q96LQ0 | |
| TDVLFGLLREVVARR | 661 | Q92620 | |
| VATFVRERAAVEELL | 61 | Q15814 | |
| LLRFSLDDRVDGVIA | 446 | Q9BWH6 | |
| VRTLGLREAEIEAVE | 351 | Q93038 | |
| IGANRRTEIIEDLAF | 161 | Q9Y5L0 | |
| EITILSVGRFRVARI | 341 | Q969Z4 | |
| VFTREELGLLDLAQR | 16 | A6NK53 | |
| RVITSRIVGGEDAEL | 36 | Q9Y6M0 | |
| REAVVALSFLIEGTI | 206 | Q9NVR7 | |
| ALRLIQETEVISRGF | 221 | Q9HBM0 | |
| LIRVSGIAEVEETGR | 581 | Q96PF1 | |
| GVVIETLDLVLETFR | 531 | Q6ZVT0 | |
| IVDERVDETSGLIVR | 106 | O95185 | |
| IGLVLRTARERFLVE | 221 | P51784 | |
| GRIEAIEGSREDIVV | 576 | P51784 | |
| FLALVEEVEDRGTVV | 671 | Q9H3U1 | |
| GEEDIVDFLRRLVES | 41 | Q49AM3 | |
| AEIRQTLDRLLVGDF | 686 | Q5THJ4 | |
| DVLGFLRVVRFVRIL | 341 | Q03721 | |
| TARDRVGVQDFVLLE | 41 | O00159 |